Insider Transactions in Q2 2023 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
769,230
+6.29%
|
$9,999,990
$13.0 P/Share
|
|
Jun 05
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
1,229
-0.1%
|
$19,664
$16.0 P/Share
|
|
May 16
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
955
-0.36%
|
$12,415
$13.12 P/Share
|
|
May 16
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
692
-0.06%
|
$8,996
$13.12 P/Share
|
|
May 16
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,104
-0.26%
|
$40,352
$13.12 P/Share
|
|
May 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.68%
|
-
|
|
May 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
May 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.35%
|
-
|